Literature DB >> 15116088

The effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder-a placebo-controlled double-blind study.

T Hamazaki, S Hirayama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15116088     DOI： 10.1038/sj.ejcn.1601888

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN： 0954-3007            Impact factor:   4.016


× No keyword cloud information.
  4 in total

1.  Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial.

Authors:  Toshiko Matsudaira; Rachel V Gow; Joanna Kelly; Caroline Murphy; Laura Potts; Alexander Sumich; Kebreab Ghebremeskel; Michael A Crawford; Eric Taylor
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-12       Impact factor: 2.576

Review 2.  Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Authors:  Donna Gillies; John Kh Sinn; Sagar S Lad; Matthew J Leach; Melissa J Ross
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

Review 3.  Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment.

Authors:  Anja Königs; Amanda J Kiliaan
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-26       Impact factor: 2.570

4.  Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder.

Authors:  Paul J Sorgi; Edward M Hallowell; Heather L Hutchins; Barry Sears
Journal:  Nutr J       Date:  2007-07-13       Impact factor: 3.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.